EUVIMEDEUVIMED entdecken
Crossref

Long-Term Survival of Cancer Patients Following COVID-19 Infection: Prognostic Value of Inflammatory Indices and Vaccination Status

Seda Sali, Mehmet Akif Ötegeçeli, Şule Özalp, Ahmet Bilgehan Şahin, Birol Ocak, Mürsel Sali, Eyüp Çoban, Burcu Caner, Sibel Oyucu Orhan, Adem Deligönül, Türkkan Evrensel, Erdem Çubukçu

Uludağ Üniversitesi Tıp Fakültesi Dergisi · 26.03.2026 · 52 · 1898579

DOI: 10.32708/uutfd.1898579 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Uludağ Üniversitesi Tıp Fakültesi Dergisi, online erschienen am 26.03.2026. Verfasst von Seda Sali und 11 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Gefördert von: The authors declare that this research received no external funding..

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The survival outcomes of cancer patients exposed to Coronavirus Disease 2019 (COVID-19), the duration required to resume oncological treatment, and the subsequent course of their malignancy remain areas with limited data. This retrospective study evaluated 128 cancer patients hospitalized for COVID-19 treatment between April 2020 and October 2023. Of the cohort, 39.8% were women and 60.2% were men. Findings revealed that patients with metastatic lung involvement faced a 3.34-fold increased risk of death during the acute infection. In the post-COVID survival cohort, multivariate analysis indicated that younger age, higher hemoglobin levels, higher systemic inflammatory index, lower pan-immune inflammation value, and absence of active cancer were associated with longer survival. Additionally, vaccine-related survival differences were observed; however, these findings should be interpreted cautiously as they likely reflect confounding factors such as prioritizing high-risk patients for certain vaccine types rather than a direct causal relationship. Notably, while treatment delays were common among patients with disease progression, these delays did not result in a statistically significant difference in overall survival during the long-term follow-up.

Förderung

  • The authors declare that this research received no external funding.

Zitieren

APA

Sali, S., Ötegeçeli, M. A., Özalp, Ş., Şahin, A. B., Ocak, B., Sali, M., Çoban, E., Caner, B., Orhan, S. O., Deligönül, A., Evrensel, T., & Çubukçu, E. (2026). Long-Term Survival of Cancer Patients Following COVID-19 Infection: Prognostic Value of Inflammatory Indices and Vaccination Status. Uludağ Üniversitesi Tıp Fakültesi Dergisi, 52, 1898579. https://doi.org/10.32708/uutfd.1898579

Vancouver

Sali S, Ötegeçeli MA, Özalp Ş, Şahin AB, Ocak B, Sali M, et al. Long-Term Survival of Cancer Patients Following COVID-19 Infection: Prognostic Value of Inflammatory Indices and Vaccination Status. Uludağ Üniversitesi Tıp Fakültesi Dergisi. 2026;52:1898579. doi:10.32708/uutfd.1898579

BibTeX
@article{Sali2026,
  author = {Sali, Seda and Ötegeçeli, Mehmet Akif and Özalp, Şule and Şahin, Ahmet Bilgehan and Ocak, Birol and Sali, Mürsel and Çoban, Eyüp and Caner, Burcu and Orhan, Sibel Oyucu and Deligönül, Adem and Evrensel, Türkkan and Çubukçu, Erdem},
  title = {Long-Term Survival of Cancer Patients Following COVID-19 Infection: Prognostic Value of Inflammatory Indices and Vaccination Status},
  journal = {Uludağ Üniversitesi Tıp Fakültesi Dergisi},
  year = {2026},
  volume = {52},
  pages = {1898579},
  doi = {10.32708/uutfd.1898579}
}
Kostenlos starten →